Rions India Biotech Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.87%
- Profit Growth 309.00%
- Ebitda -144.89%
- Net Worth 87.53%
- Total Assets 69.05%
About Rions India Biotech Solutions
Rions India Biotech Solutions Private Limited (RIBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2011 and has a history of 14 years. Its registered office is in Delhi, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Kushwaha and Sarvjit Kaur serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29210DL2011PTC213529
- Company No.
213529
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2011
- Date of AGM
02 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rions India Biotech Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Kushwaha  | Director | 08-Feb-2011 | Current |
| Sarvjit Kaur | Director | 08-Feb-2011 | Current |
Financial Performance of Rions India Biotech Solutions.
Rions India Biotech Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.87% increase. The company also saw a substantial improvement in profitability, with a 309% increase in profit. The company's net worth Soared by an impressive increase of 87.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rions India Biotech Solutions?
In 2019, Rions India Biotech Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rions India Lab Water Systems Private LimitedArvind Kushwaha and Sarvjit Kaur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rions India Biotech Solutions?
Unlock and access historical data on people associated with Rions India Biotech Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rions India Biotech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rions India Biotech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.